Metsera Inc - MTSR Company Short-Term Debt

Public company logo of Metsera Inc (MTSR)

Metsera Inc (MTSR) relies on an asset-light model, outsourcing drug production to external contractors. High early-stage risks and a lack of profitability create a speculative asset profile while laboratories upgrade equipment to meet global standards. The evolution of short-term debt load on the chart demonstrates market sentiment, with the indicator holding around 0.00, balancing financial stability and growth potential.

MTSR (Metsera, Inc.) Company Short-Term Debts history from 02/01/2025 to 11/29/2025

Summary analytical data breakdowns for Metsera Therapeutics (MTSR)

- price and consensus price forecast:
Price Chart Metsera|MTSR - Fair Value Consensus
- market capitalization data:
Market Value Metsera Inc|MTSR - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Metsera|MTSR - Book Capitalization|Market Cap to Net Assets Ratio metsera.com|MTSR - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Metsera Inc|MTSR - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Metsera Inc|MTSR - Company Cumulative Debt|Debt to Book Value Metsera Inc|MTSR - Amount of Long-Term Liabilities|Company Short-Term Debts Metsera
Initial company analysis:MTSR (Metsera)
Flagship merchandise of Metsera Therapeutics

The absence of commercial revenue as Metsera Inc. (MTSR) completes critical drug trials makes liquidity management a priority for survival in a competitive environment. By analyzing short-term debt statistics, an investor assesses obligations maturing within one year, where a reduction in debt confirms solvency, while an increase signals the risk of cash flow gaps given limited cash reserves.

Competitors of Metsera Inc (MTSR)

Company Short-Term Debt Ascendis Pharma (ASND)|MDGL: Company Short-Term Loans and Borrowings|CORT (Corcept) - Company Short-Term Debt|Rhythm Corp (RYTM) - Company Current Liabilities|AKRO (Akero Therapeutics) - Company Short-Term Debts|Company Short-Term Debts moonlaketx.com (MLTX)|Crinetics (CRNX) - Company Current Liabilities|Company Short-Term Loans and Borrowings NAMS (NewAmsterdam Pharma Company)|Soleno - Company Short-Term Debt|Company Current Liabilities Amicus Corp FOLD|ETNB (89bio, Inc.) - Company Short-Term Debts|agios.com (AGIO) - Short-Term Debt|GPCR - Company Current Liabilities|MiMedx Group Inc (MDXG) - Amount of Current Liabilities|RZLT (Rezolute Corp) - Company Short-Term Debts|Company Short-Term Debts Lexicon Corp|Company Short-Term Debts MBX Biosciences Inc (MBX)|Company Short-Term Debt ALT (altimmune.com)|AARD: Company Short-Term Debt|Sagimet Biosciences, Inc. - Short-Term Debt|BIOA - Company Short-Term Debt|BMEA - Company Short-Term Debt|quincetx.com - Company Short-Term Debts|GUTS (fractyl.com) - Short-Term Debt Volume|VTVT: Company Short-Term Debt|Short-Term Debt Volume ATPC|Company Short-Term Debt PLUR (Pluri Inc.)|Company Current Liabilities SYBX (synlogictx.com)|Lipocine Inc. - Company Short-Term Debt|Company Current Liabilities Matinas BioPharma Holdings, Inc. MTNB|SPRB (Spruce Biosciences) - Company Short-Term Debts|Galecto Inc (GLTO) - Short-Term Debt|CTCX - Company Current Liabilities|LUMO (Lumos Therapeutics) - Amount of Current Liabilities|ONVO: Company Short-Term Debt|Short-Term Debt Volume radiuspharm.com